
Chemical and Pharmaceutical Bulletin p. 1532 - 1537 (1999)
Update date:2022-07-31
Topics:
Akasaka, Kozo
Komatsu, Yuki
Tagami, Katsuya
Shimizu, Toshikazu
Shimomura, Naoyuki
Naka, Hiroshi
Hayashi, Kenji
Negi, Shigeto
An efficient synthetic process for the key intermediate of a new peptidomimetic dual metalloprotease inhibitor, ER-40133, was developed. (5R)- Methyl-6-oxopipecolic acid ester (3a), prepared from L-α,-aminoadipic acid, was chemoselectively reduced to the
View Morewebsite:http://www.sjc.com.tw
Contact:(886) 2-2396-6223
Address:14Fl., No. 99. Sec. 2, Jen Ai Road
Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
website:http://www.jlpharms.com
Contact:86-571-86982636
Address:Rm A606, Fuyi Center, jianqiao street
Contact:0086-29-89196322
Address:North of the Fifth Keji Road, Hi-Tech Industrial Zone, Xi'an City, Shaanxi Province, China
Contact:+36(21)2523420
Address:Head office: 1102 Budapest, SZENT LASZLO TER 24/B. 1/1., HUNGARY / CHINA
Xi'an North Information Industry Co., Ltd. Weilv Chemical Department
Contact:+86-29-88156413
Address:Jixiang Road 99 Xi'an Shaanxi Province
Doi:10.1016/j.molstruc.2012.12.018
(2013)Doi:10.3109/14756366.2011.653355
(2013)Doi:10.1039/c3ra41640b
(2013)Doi:10.1021/ol400493x
(2013)Doi:10.1016/j.jorganchem.2013.01.013
(2013)Doi:10.1021/om400025h
(2013)